Efficacy and Safety of Deferasirox (Exjade (R)) in Reducing Cardiac Iron in Patients with beta-Thalassemia Major: Results from the Cardiac Substudy of the EPIC Trial

Pennell, DudleyPorter, John B.Cappellini, Maria DomenicaLi, Chi-KongAydinok, YesimLee, Chan LeeKattamis, AntonisSmith, GillianHabr, DanyDomokos, GaborHmissi, AbdelTaher, Ali2019-10-272019-10-2720080006-4971https://hdl.handle.net/11454/4196150th Annual Meeting of the American-Society-of-Hematology -- DEC 06-09, 2008 -- San Francisco, CAeninfo:eu-repo/semantics/closedAccessEfficacy and Safety of Deferasirox (Exjade (R)) in Reducing Cardiac Iron in Patients with beta-Thalassemia Major: Results from the Cardiac Substudy of the EPIC TrialConference Object1121113181318WOS:000262104704480Q1